One-two Punch Impairs Chemo Resistance in Mice with Ovarian Cancer

One-two Punch Impairs Chemo Resistance in Mice with Ovarian Cancer
Platinum-based chemotherapy is a highly effective treatment approach for ovarian cancer, but most patients will eventually become resistant and stop responding to it. Now, researchers at the Wistar Institute may have found a way to prevent that resistance from developing, using a new class of drugs called bromodomain and extraterminal (BET) inhibitors. The study, “BET Inhibitors Suppress

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *